Combinations ; See Below
| Brand Name | Manufacturer Name | Distributor | Drug Strength | Packaging | Formulation | Formulation Strength | Price |
|---|---|---|---|---|---|---|---|
| Ltd. | Ltd | mg | 30 | Tablet | per tablet | KES | |
| Emtricitabine More info | |
|---|---|
| Mode Of Action | Nucleoside reverse transcriptase inhibitors (NRTIs) that are converted by cellular cells? enzymes to active phosporylated metabolites that inhibit viral reverse transcriptase and viral DNA synthesis. |
| Drug Indication | HIV infection in combination with other ARVs. |
| Precautions | Decreased dose in case of renal impairment; to watch out on the possibility of rebound of hepatitis B infection after stopping treatment in case of HIV/hepatitis B coinfections. |
| Contra-Indications | Children below 4 years; no safety data is currently available. |
| Side Effects | Rash; diarrhoea; cough; hyperpigmentation of palm or/and sole especially in women. |
| Drug Category | DRUGS ACTING ON INFECTIONS |
| Drug Sub-Category | Hiv Chemotherapy |